NCT03220178 Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy Status TERMINATED Phase PHASE4
NCT03217604 A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of PF-06852231 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03210961 A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis Status COMPLETED Phase PHASE1
NCT03205267 Phase II Study Testing the Tolerability and the Efficacy of Bosutinib in Chronic Phase CML Patients Status UNKNOWN Phase PHASE2
NCT03192215 AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke Status TERMINATED Phase PHASE3
NCT03190577 Assessment of the Prevalence of TTR Amyloid Neuropathy in a Population of Patients With Neuropathy of Unknown Aetiology Status COMPLETED Phase NA
NCT03189745 A Study To Evaluate A Booster Dose Of Menacwy-tt Vaccine Administered 10 Years After Healthy Subjects Aged 11-17 Years Received Either Menacwy-tt Vaccine (Nimenrix(Registered)) Or Mencevax Acwy(Registered). Status COMPLETED Phase PHASE3
NCT03185481 Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations Status TERMINATED Phase PHASE2
NCT03184168 Single-dose Study of [14C]Lorlatinib (PF-06463922) Metabolism In Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT03181841 Effects of PF-06412562 on Value-based Decision-making in Healthy Individuals Status COMPLETED Phase PHASE1
NCT03178071 Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 Positive Status NO_LONGER_AVAILABLE Phase N/A
NCT03170609 A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age Status COMPLETED Phase PHASE2
NCT03170206 Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT03164291 Effectiveness of Rifabutin in the Treatment of Mycobacterium Avium Complex Status COMPLETED Phase PHASE3
NCT03162900 A Phase 1 Study To Evaluate The Effect Of Glasdegib On The Cardiac Repolarization In Healthy Subjects Status COMPLETED Phase PHASE1
NCT03159936 Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Status TERMINATED Phase EARLY_PHASE1
NCT03159117 Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma Status COMPLETED Phase PHASE1
NCT03148795 A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE2